Evidence map›Paper›PMID 40220003›Full record

ArticleThe Plant journal : for cell and molecular biology2025

Berberine bridge enzyme-like oxidases orchestrate homeostasis and signaling of oligogalacturonides in defense and upon mechanical damage.

Ascenzo Salvati, Alessandra Diomaiuti, Federica Locci, Matteo Gravino, Giovanna Gramegna, Muhammad Ilyas, Manuel Benedetti, Sara Costantini, Monica De Caroli, Baptiste Castel and 4 more

Abstract read
In one paragraph

Article in The Plant journal : for cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Frontiers in plant science · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ascenzo Salvati *Department of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.ORCID 0000-0002-8382-638X
Alessandra Diomaiuti *Department of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.ORCID 0000-0002-3758-3743
Federica LocciDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.
Matteo GravinoDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.
Giovanna GramegnaDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.ORCID 0000-0001-8585-7801
Muhammad IlyasDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.
Manuel BenedettiDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.
Sara CostantiniDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.
Monica De CaroliDepartment of Biological and Environmental Sciences and Technologies, University of Salento, Campus Ecotekne, Lecce, 73100, Italy.ORCID 0000-0001-8668-4711
Baptiste CastelThe Sainsbury Laboratory, University of East Anglia, Norwich Research Park, Colney Lane, Norwich, NR4 7UH, UK.
Jonathan D G JonesThe Sainsbury Laboratory, University of East Anglia, Norwich Research Park, Colney Lane, Norwich, NR4 7UH, UK.ORCID 0000-0002-4953-261X
Felice CervoneDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.ORCID 0000-0001-8141-5352
Daniela PontiggiaDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.ORCID 0000-0002-0980-107X
Giulia De LorenzoDepartment of Biology and Biotechnologies, 'Charles Darwin' Sapienza University of Rome, Rome, 00185, Italy.

Funding

Ministero dell'Università e della Ricerca PRIN 2022WLZ4HBSapienza Università di Roma AR1231888D22C2F6Sapienza Università di Roma RG12117A898EABE0Sapienza Università di Roma RM123188F70CF274Sapienza Università di Roma RM123188F796E238
6 · The paper itself

Abstract

Plant immunity is triggered by endogenous elicitors known as damage-associated molecular patterns (DAMPs). Oligogalacturonides (OGs) are DAMPs released from the cell wall (CW) demethylated homogalacturonan during microbial colonization, mechanical or pest-provoked mechanical damage, and physiological CW remodeling. Berberine bridge enzyme-like (BBE-l) proteins named OG oxidases (OGOXs) oxidize and inactivate OGs to avoid deleterious growth-affecting hyper-immunity and possible cell death. Using OGOX1 over-expressing lines and ogox1/2 double mutants, we show that these enzymes determine the levels of active OGs vs. inactive oxidized products (ox-OGs). The ogox1/2-deficient plants have elevated levels of OGs, while plants overexpressing OGOX1 accumulate ox-OGs. The balance between OGs and ox-OGs affects disease resistance against Pseudomonas syringae pv. tomato, Pectobacterium carotovorum, and Botrytis cinerea depending on the microbial capacity to respond to OGs and metabolize ox-OGs. Gene expression upon plant infiltration with OGs reveals that OGOXs orchestrate OG signaling in defense as well as upon mechanical damage, pointing to these enzymes as apoplastic players in immunity and tissue repair.

Indexed as

ArabidopsisArabidopsis ProteinsOligosaccharidesOxidoreductasesPectinsPlant DiseasesBerberineBotrytisCell WallDisease ResistanceGene Expression Regulation, PlantHomeostasisPectobacterium carotovorumPlant ImmunityPseudomonas syringaeSignal TransductionArabidopsis ProteinsBerberineoligogalacturonic acidOligosaccharidesOxidoreductasesPectinsberberine bridge enzyme‐like oxidasesDamage‐Associated Molecular Patternsoligogalacturonidesplant immunity

Identifiers

PMID40220003
PMCPMC11992967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.